p120 catenin affects cell-cell adhesion by interacting with the highly conserved juxtamembrane domain of classical cadherins, and has additional roles in both the cytoplasm and the nucleus. Three recent reports indicate that cytoplasmic p120 can modulate the activities of RhoA, Rac, and Cdc42, leading to altered cell morphology and increased motility. Cadherin binding blocks these cytoplasmic p120 effects, suggesting an elegant and previously unexpected mechanism for regulating the balance between adhesive and motile cellular phenotypes. These observations also provide a potential explanation for the metastatic phenotype shown by cancer cells that have lost E-cadherin expression. Our long-term goal is to understand, and prevent or develop treatments for, tumor metastasis. Specifically, in this project, we seek to (1) elucidate the mechanism(s) by which p120 affects different Rho GTPases, (2) test the hypothesis that cytoplasmic p120 can promote invasiveness in vitro and in vivo, and (3) clarify the role of kinesin in p120 function.
In Aim 1 structure-function analysis and selective uncoupled mutants of p120 will be used, and specific protein-protein interactions tested, to determine whether p120 affects RhoA, Rac and Cdc42 via the same or distinct mechanisms.
In Aim 2, we will test in vitro whether cadherin-unbound p120 promotes cell motility and induces invasiveness. Treatments that affect p120 localization or function in cultured cells will also be tested for their effects on invasiveness, after injection of the cells into nude mice. Finally, in Aim3 we will test the role of the p120-kinesin association in the activity of Rho GTPases, cadherin function, cytoskeletal dynamics and cell motility. By exploring the role of p120 catenin in the integration of cadherin and Rho signaling cascades, we expect to determine whether p120 acts as a cell contact-sensitive switch, mediating contact inhibition of motility, and cadherin-mediated suppression of invasiveness. We expect that elucidating p120's functional and physical interaction domains will allow the future generation of compounds that target particular p120 functions, as the basis of novel cancer treatments. We believe that because p120 is bound to cadherins in normal cells, selectively targeting the p120 functions that promote invasiveness in the cadherin-uncoupled state would be uniquely effective in cadherin-deficient malignant cells.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA100467-05
Application #
7417821
Study Section
Cell Development and Function Integrated Review Group (CDF)
Program Officer
Woodhouse, Elizabeth
Project Start
2004-08-01
Project End
2011-05-31
Budget Start
2008-06-01
Budget End
2011-05-31
Support Year
5
Fiscal Year
2008
Total Cost
$262,409
Indirect Cost
Name
Mayo Clinic Jacksonville
Department
Type
DUNS #
153223151
City
Jacksonville
State
FL
Country
United States
Zip Code
32224
Kourtidis, Antonis; Necela, Brian; Lin, Wan-Hsin et al. (2017) Cadherin complexes recruit mRNAs and RISC to regulate epithelial cell signaling. J Cell Biol 216:3073-3085
Kourtidis, Antonis; Lu, Ruifeng; Pence, Lindy J et al. (2017) A central role for cadherin signaling in cancer. Exp Cell Res 358:78-85
Kourtidis, Antonis; Anastasiadis, Panos Z (2016) PLEKHA7 defines an apical junctional complex with cytoskeletal associations and miRNA-mediated growth implications. Cell Cycle 15:498-505
Kourtidis, Antonis; Ngok, Siu P; Pulimeno, Pamela et al. (2015) Distinct E-cadherin-based complexes regulate cell behaviour through miRNA processing or Src and p120 catenin activity. Nat Cell Biol 17:1145-57
Huveldt, Deborah; Lewis-Tuffin, Laura J; Carlson, Brett L et al. (2013) Targeting Src family kinases inhibits bevacizumab-induced glioma cell invasion. PLoS One 8:e56505
Ngok, Siu P; Geyer, Rory; Liu, Miaoliang et al. (2012) VEGF and Angiopoietin-1 exert opposing effects on cell junctions by regulating the Rho GEF Syx. J Cell Biol 199:1103-15
Rodriguez, Fausto J; Lewis-Tuffin, Laura J; Anastasiadis, Panos Z (2012) E-cadherin's dark side: possible role in tumor progression. Biochim Biophys Acta 1826:23-31
Lewis-Tuffin, Laura J; Rodriguez, Fausto; Giannini, Caterina et al. (2010) Misregulated E-cadherin expression associated with an aggressive brain tumor phenotype. PLoS One 5:e13665
Orlichenko, Lidiya; Geyer, Rory; Yanagisawa, Masahiro et al. (2010) The 19-amino acid insertion in the tumor-associated splice isoform Rac1b confers specific binding to p120 catenin. J Biol Chem 285:19153-61
Soto, Edwin; Yanagisawa, Masahiro; Marlow, Laura A et al. (2008) p120 catenin induces opposing effects on tumor cell growth depending on E-cadherin expression. J Cell Biol 183:737-49

Showing the most recent 10 out of 14 publications